stockrow
Wednesday 4 November 2026
Export AUTL’s income statement to Excel — free account
Autolus Therapeutics PLC Sponsored ADR
AUTL Healthcare Biotechnology
Autolus Therapeutics PLC Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $75.4 million, up 644.9% from fiscal 2024.
- Revenue
- +118.4%
- EPS
- +16.7%
- Free cash flow
- +67.6%
Quarter to June 2026, against a year earlier
1.38
0.04
−2.82%
Follow AUTL
Alert me
Autolus Therapeutics PLC Sponsored ADR (AUTL) P/E ratio
Autolus Therapeutics PLC Sponsored ADR has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 0.0× (November 2026) — the current reading is the highest in ten years.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 0.0× | — |
| FY2024 | 0.0× | — |
| FY2023 | 0.0× | — |
| FY2022 | 0.0× | — |
| FY2021 | 0.0× | — |
| FY2020 | 0.0× | — |
| FY2019 | 0.0× | — |
| FY2018 | 0.0× | — |
| FY2017 | 0.0× | — |
| FY2016 | 0.0× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 0.0× | — |
| Mar 2026 | 0.0× | — |
| Dec 2025 | 0.0× | — |
| Sep 2025 | 0.0× | — |
| 26 more quarters | Free account |
Against its own ten years
Low 0.0×
High 0.0×
Ten-year median
0.0×
Current reading's percentile
100
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| FENC Adherex Technologies Inc. compare | n/m |
| AVTX Avalo Therapeutics, Inc. compare | n/m |
| TECX Tectonic Therapeutic, Inc. compare | n/m |
| RZLT Rezolute, Inc. compare | n/m |
| ZURA Zura Bio Limited compare | n/m |
| AUTL Autolus Therapeutics PLC Sponsored ADR | n/m |
| ALLO Allogene Therapeutics, Inc. compare | n/m |
| MPLT MapLight Therapeutics, Inc. compare | n/m |
| TRXB TRex Bio Inc. compare | — |
| Biotechnology industry median | 10.6× |
| Healthcare sector median | 24.6× |
| Market median | 18.3× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)